An analysis by the Commonwealth Fund "shows that the Affordable Care Act’s health insurance coverage provisions have helped the U.S. make progress toward ensuring that everyone, regardless of race or ethnicity, has access to the health care they need," says Pamela Riley, M.D. She is the organization’s vice president for delivery system reform and a coauthor of the report.
Ending Healthcare Payments: Bursting the Balloon or Just Squeezing It?
President Trump has threatened to cancel federal health insurance payments called “cost-sharing reductions.” He hopes this collapses the Affordable Care Act’s health insurance exchanges, creating leverage for further repeal negotiations with recalcitrant Senators and Congressmen. However, the Congressional Budget Office (CBO) reported that ending these payments would actually increase federal costs by $194 billion over ten years and cause a million people to lose health insurance next year.
CBO Report Projecting the Effects of Stopping Cost-sharing Reductions to Insurers
A report by the non-partisan Congressional Budget Office and the staff of the Joint Committee on Taxation estimates the effect of terminating federal payments to insurers to cover costs incurred when offering plans with reduced deductibles, copayments, and other cost sharing to some people who purchase plans through the marketplaces established under the Affordable Care Act (ACA).
District of Columbia Health Benefits Exchange Authority Working Group Being Chaired by HPM Professor
Professor Leighton Ku is chairing a working group for the District of Columbia Health Benefits Exchange Authority that will develop proposals to safeguard and strengthen the District’s health insurance exchange in light of potential administrative or legislative threats. He also testified to the Maryland Legislative Health Insurance Coverage Protection Commission, a body that is considering similar issues in Maryland, focusing on his recent research about the possible economic consequences of ef
Inoculating Healthcare Businesses with Enterprise Resilience
At a time when the nationwide debate over Health Reform has no clear endpoint, executives in the health related sectors should take a pragmatic approach and guide their organizations to prepare and plan for change. While uncertainty is at an all-time high, providers, insurers and pharma/biotech businesses should embrace a posture of resilience. For example, the Enterprise Resilience model enables business in different sectors to prepare, plan and align their efforts to address the implications of various scenarios related to health reform. It is a defensive posture in which they must und